Optimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants
Primary Purpose
Gestational Diabetes
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Intervention
Sponsored by
About this trial
This is an interventional treatment trial for Gestational Diabetes focused on measuring gestational diabetes, women, infants, blood glucose, weight, adiposity, health behaviors, self-efficacy
Eligibility Criteria
Inclusion Criteria:
- Women between 22-36 weeks of pregnancy who are diagnosed with GDM
- A diagnosis of GDM during the current pregnancy by two or more 100g Oral Glucose Tolerance Test (OGTT) values exceeding established thresholds (fasting 95, 1h 180, 2h 155, 3h 140 mg/dL)
- Age 18-45 years old
A pre-pregnancy body mass index > 25kg/m2
- Ability to read and write in English
- Willingness to consent for themselves and their infant
Exclusion Criteria:
- They have a A1c ≥ 6.5 mg/dL (Type 2 diabetes)
Sites / Locations
- UNC-Rex Health Care
- WakeMed
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
intervention
Wait-listed control group
Arm Description
Breastfeeding, progression to type 2 diabetes, nutrition, and exercise education, coping skills training, exercise training, a home-based exercise program and educational and motivational text messaging.
Wait-listed control group receive usual care delivered by their health care provider and after completion of their time in the study they are offered the intervention
Outcomes
Primary Outcome Measures
fasting blood glucose
Change in fasting blood glucose in mothers
weight (body mass index)
Change in weight (body mass index)in mothers
Secondary Outcome Measures
oral glucose tolerance test
Change in oral glucose tolerance test in mothers
insulin levels
Change in insulin levels in mothers
homeostasis model assessment
Change in homeostasis model assessment calculation in mothers
hemoglobin A1c
Change in hemoglobin A1c in mothers
complete lipid panel
Change in complete lipid panel in mothers
blood pressure
Change in blood pressure in mothers
adiposity
Change in adiposity (waist circumference, triceps and subscapular skin folds)in mothers
health behaviors
Change in health behaviors (Health Promoting Lifestyle Profile II, Adult Health Behavior Survey, and Accelerometry for 7 days) in mothers
self-efficacy
Change in self-efficacy in mothers
infant weight status
weight status (weight-for-length) in children
breastfeeding
Change in breastfeeding (weeks until stopped breastfeeding, weeks exclusively breastfed, and intensity of breastfeeding) in infants
Full Information
NCT ID
NCT01809431
First Posted
March 10, 2013
Last Updated
June 1, 2015
Sponsor
University of North Carolina, Chapel Hill
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
1. Study Identification
Unique Protocol Identification Number
NCT01809431
Brief Title
Optimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants
Official Title
Optimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants
Study Type
Interventional
2. Study Status
Record Verification Date
June 2015
Overall Recruitment Status
Completed
Study Start Date
May 2012 (undefined)
Primary Completion Date
July 2014 (Actual)
Study Completion Date
July 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of North Carolina, Chapel Hill
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to determine whether a 14 week intervention is successful in improving outcomes for women with gestational diabetes mellitus and their infants.
Detailed Description
Women who are diagnosed with gestational diabetes are at increased risk for developing prediabetes and type 2 diabetes. To date, there have been few interdisciplinary interventions that target predominantly ethnic minority low-income women diagnosed with gestational diabetes. Programs are needed that intervene in the prenatal period to teach women the importance of breastfeeding to improve metabolic control and infant health and continue after birth to promote improved nutrition and exercise patterns and weight loss. Using a two-group, repeated measures experimental design, this proposed study will test a 14-week intensive intervention on the benefits of breastfeeding, understanding gestational diabetes and risk of progression to prediabetes and type 2 diabetes, nutrition and exercise education, coping skills training, and physical activity (Phase I) and 3 months of continued monthly contact (Phase II) to help overweight women diagnosed with gestational diabetes improve metabolic, clinical, weight, adiposity, health behaviors and self-efficacy. Trends in breastfeeding duration and intensity, maternal infant feeding behavior, infant growth trajectory (weight-for-length) will also be measured. A total of 100 African American, bilingual Hispanic, and non-Hispanic White women diagnosed with gestational diabetes will be inducted and randomized by site to either the experimental or wait-list control group. Data will be collected at Time 1 (Baseline at 22-36 weeks pregnant), Time 2 (6 weeks postpartum), Time 3 (4 months postpartum and completion of Phase I), Time 4 (7 months postpartum and completion of Phase II), and Time 5 (10 months postpartum and after 3 months on their own). Primary maternal outcomes will include fasting blood glucose and weight (BMI). Secondary maternal outcomes will include clinical outcomes (oral glucose tolerance test, insulin levels, Homeostasis Model Assessment calculation, Hemoglobin A1c, complete lipid panel, and blood pressure); adiposity (waist circumference, triceps and subscapular skin folds); health behaviors (Health Promoting Lifestyle Profile II, Adult Health Behavior Survey, and Accelerometry for 7 days); and self-efficacy (Eating Self-Efficacy, Exercise Self-Efficacy Scale, and Breastfeeding Self-Efficacy Scale). Infant outcomes will include data on weight status (weight-for-length) and breastfeeding (weeks until stopped breastfeeding, weeks exclusively breastfed, and intensity of breastfeeding). Data analysis will include analysis of field notes, post-intervention interviews, and recruitment and retention efforts. Linear mixed-effects random coefficients models will be constructed to measure the effects of the intervention compared to the wait-list control group. Increasing breastfeeding and decreasing overweight in postpartum women who were diagnosed with gestational diabetes may both improve maternal glucose homeostasis and weight and stabilize infant growth trajectory, reducing the burden of metabolic disease across two generations.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gestational Diabetes
Keywords
gestational diabetes, women, infants, blood glucose, weight, adiposity, health behaviors, self-efficacy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
200 (Actual)
8. Arms, Groups, and Interventions
Arm Title
intervention
Arm Type
Experimental
Arm Description
Breastfeeding, progression to type 2 diabetes, nutrition, and exercise education, coping skills training, exercise training, a home-based exercise program and educational and motivational text messaging.
Arm Title
Wait-listed control group
Arm Type
No Intervention
Arm Description
Wait-listed control group receive usual care delivered by their health care provider and after completion of their time in the study they are offered the intervention
Intervention Type
Behavioral
Intervention Name(s)
Intervention
Other Intervention Name(s)
breastfeeding education, progression to prediabetes and type 2 diabetes education, nutrition education, exercise education, coping skills training, exercise training, home-based exercise program, educational and motivational text messaging
Intervention Description
Using a two-group, repeated measures experimental design, this proposed study will test a 14-week intensive intervention on the benefits of breastfeeding, understanding gestational diabetes and risk of progression to prediabetes and type 2 diabetes, nutrition and exercise education, coping skills training, and physical activity (Phase I) and 3 months of continued monthly contact (Phase II) to help overweight women diagnosed with gestational diabetes improve metabolic, clinical, weight, adiposity, health behaviors and self-efficacy.
Primary Outcome Measure Information:
Title
fasting blood glucose
Description
Change in fasting blood glucose in mothers
Time Frame
Baseline to 10 months postpartum
Title
weight (body mass index)
Description
Change in weight (body mass index)in mothers
Time Frame
Baseline to 10 months postpartum
Secondary Outcome Measure Information:
Title
oral glucose tolerance test
Description
Change in oral glucose tolerance test in mothers
Time Frame
Baseline to 10 months postpartum
Title
insulin levels
Description
Change in insulin levels in mothers
Time Frame
Baseline to 10 months postpartum
Title
homeostasis model assessment
Description
Change in homeostasis model assessment calculation in mothers
Time Frame
Baseline to 10 months postpartum
Title
hemoglobin A1c
Description
Change in hemoglobin A1c in mothers
Time Frame
Baseline to 10 months postpartum
Title
complete lipid panel
Description
Change in complete lipid panel in mothers
Time Frame
Baseline to 10 months postpartum
Title
blood pressure
Description
Change in blood pressure in mothers
Time Frame
Baseline to 10 months postpartum
Title
adiposity
Description
Change in adiposity (waist circumference, triceps and subscapular skin folds)in mothers
Time Frame
Baseline to 10 months
Title
health behaviors
Description
Change in health behaviors (Health Promoting Lifestyle Profile II, Adult Health Behavior Survey, and Accelerometry for 7 days) in mothers
Time Frame
Baseline to 10 months postpartum
Title
self-efficacy
Description
Change in self-efficacy in mothers
Time Frame
Baseline to 10 months postpartum
Title
infant weight status
Description
weight status (weight-for-length) in children
Time Frame
Birth to 10 months
Title
breastfeeding
Description
Change in breastfeeding (weeks until stopped breastfeeding, weeks exclusively breastfed, and intensity of breastfeeding) in infants
Time Frame
Birth to 10 months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Women between 22-36 weeks of pregnancy who are diagnosed with GDM
A diagnosis of GDM during the current pregnancy by two or more 100g Oral Glucose Tolerance Test (OGTT) values exceeding established thresholds (fasting 95, 1h 180, 2h 155, 3h 140 mg/dL)
Age 18-45 years old
A pre-pregnancy body mass index > 25kg/m2
Ability to read and write in English
Willingness to consent for themselves and their infant
Exclusion Criteria:
They have a A1c ≥ 6.5 mg/dL (Type 2 diabetes)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Diane Berry, PhD, ANP-BC
Organizational Affiliation
University of North Carolina, Chapel Hill
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Alison Stuebe, MD
Organizational Affiliation
University of North Carolina, Chapel Hill
Official's Role
Principal Investigator
Facility Information:
Facility Name
UNC-Rex Health Care
City
Raleigh
State/Province
North Carolina
ZIP/Postal Code
27607
Country
United States
Facility Name
WakeMed
City
Raleigh
State/Province
North Carolina
ZIP/Postal Code
27610
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
27782758
Citation
Stuebe AM, Bonuck K, Adatorwovor R, Schwartz TA, Berry DC. A Cluster Randomized Trial of Tailored Breastfeeding Support for Women with Gestational Diabetes. Breastfeed Med. 2016 Dec;11(10):504-513. doi: 10.1089/bfm.2016.0069. Epub 2016 Oct 26.
Results Reference
derived
PubMed Identifier
24112417
Citation
Berry DC, Neal M, Hall EG, Schwartz TA, Verbiest S, Bonuck K, Goodnight W, Brody S, Dorman KF, Menard MK, Stuebe AM. Rationale, design, and methodology for the optimizing outcomes in women with gestational diabetes mellitus and their infants study. BMC Pregnancy Childbirth. 2013 Oct 10;13:184. doi: 10.1186/1471-2393-13-184.
Results Reference
derived
Learn more about this trial
Optimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants
We'll reach out to this number within 24 hrs